|
Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on medicines.
The web pages are not kept up to date and are for demonstration purposes only.
For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine.
|
BACK TO LIST |
European Patient Summary
|
|
|
|||||||||||||||||||
Problem list
| Condition | Onset Date | Status |
|---|---|---|
| Neuropathy due to type 2 diabetes mellitus | 2024-03-15 | active |
| Osteoporosis | 2023-09-02 | active |
| Alzheimer's disease | 2019-02-15 | active |
| Hyperlipidemia | 2018-02-09 | active |
| Acute non-ST segment elevation myocardial infarction | 2015-10-04 | active |
| Ischemic heart disease | 2008-12-19 | active |
| Hypertriglyceridemia | 2007-06-29 | active |
| Type 2 diabetes mellitus | 2006-12-08 | active |
| Metabolic syndrome X | 1977-06-24 | active |
| Prediabetes | 1974-06-07 | active |
| Essential hypertension | 1974-06-07 | active |
| Anemia | 1974-06-07 | active |
| Sleep apnea | 1974-04-02 | active |
| Sleep disorder | 1974-03-18 | active |
| Recurrent urinary tract infection | 1960-12-14 | active |
Medication list
| Medication | Since | Form | Dosage | Reason |
|---|---|---|---|---|
| Simvastatin 10 mg oral tablet | 2025-03-22 | Oral tablet | 1 tablet (10 mg) by mouth once daily | Hyperlipidemia |
| Amlodipine (as amlodipine besylate) 2.5 mg oral tablet | 2025-03-21 | Oral tablet | 1 tablet (2.5 mg) by mouth once daily | Essential hypertension (disorder) |
| Alendronic acid (as alendronate sodium) 10 mg oral tablet | 2025-03-21 | Oral tablet | 1 tablet (10 mg) once daily | |
| 24 HR Donepezil hydrochloride 10 MG / Memantine hydrochloride 28 MG Extended Release Oral Capsule | 2020-03-12 | 28 mg / 10 mg once daily | Alzheimer's disease (disorder) | |
| Atenolol 25 mg oral tablet | 2015-10-05 | Oral tablet | 1 tablet (25 mg) by mouth once daily | |
| Atorvastatin (as atorvastatin calcium) 40 mg oral tablet | 2015-10-05 | Oral tablet | 1 tablet (40 mg) by mouth once daily | |
| losartan potassium 25 MG Oral Tablet | 2015-10-05 | 1 tablet (25 mg) by mouth once daily | ||
| Clopidogrel (as clopidogrel bisulfate) 75 mg oral tablet | 2008-12-26 | Oral tablet | 1 tablet (75 mg) by mouth once daily | |
| Simvastatin 20 mg oral tablet | 2008-12-26 | Oral tablet | 1 tablet (20 mg) by mouth once daily | |
| Nitroglycerin 400 microgram/actuation sublingual spray | 2008-12-26 | Sublingual spray | 400 micrograms (1 spray) sublingually as needed for chest pain, may repeat every 5 minutes as needed, up to 3 sprays in 15 minutes | |
| Metoprolol tartrate (as metoprolol succinate) 100 mg prolonged-release oral tablet | 2008-12-26 | Prolonged-release oral tablet | 1 tablet (100 mg) once daily |
Allergies and Intolerances
| Allergy/Intolerance | Onset Date | Status | Type | Reaction |
|---|---|---|---|---|
| Aspirin | 1943-10-30 | active | medication | |
| Lisinopril | 1943-10-30 | active | medication | |
| Soyabean | 1943-10-30 | active | food | Finding of vomiting (finding) (moderate) Diarrhea (finding) (mild) |
| Allergy to substance | 1943-10-30 | active | environment |
Procedure History list
| Procedure | Date | Reason |
|---|---|---|
| Pre-discharge assessment | 2023-09-14 | - |
| 2023-09-14 | - | |
| Speech and language therapy regime | 2023-09-13 | - |
| Nursing care/supplementary surveillance | 2023-09-13 | - |
| Professional / ancillary services care | 2023-09-10 | - |
| History AND physical examination | 2023-09-02 | - |
| Pelvis X-ray | 2023-09-02 | - |
| Admission to orthopedic department | 2023-09-02 | Closed fracture of hip |
| Bone density scan | 2023-09-02 | Closed fracture of hip |
| Initial patient assessment | 2023-09-02 | - |
| Development of individualized plan of care | 2023-09-02 | - |
| Sleep apnea assessment | 2020-05-15 | Sleep disorder (disorder) |
| Depression screening | 2020-05-15 | - |
| Medication reconciliation | 2020-05-15 | - |
| Assessment of health and social care needs | 2020-05-15 | - |
| Assessment of anxiety | 2020-05-15 | - |
| Screening for drug abuse | 2020-05-15 | - |
| Assessment using Morse Fall Scale | 2020-05-15 | - |
| Screening for domestic abuse | 2020-05-15 | - |
| Assessment of substance use | 2020-05-15 | - |
| 2020-05-15 | - | |
| Patient discharge | 2018-04-04 | - |
| Hospice care | 2018-04-03 | - |
| Notifications | 2018-03-30 | - |
| Certification procedure | 2018-03-30 | - |
| Angiography of coronary artery | 2015-10-05 | - |
| Transthoracic echocardiography | 2015-10-05 | - |
| Laboratory test | 2015-10-04 | - |
| Electrocardiographic procedure | 2015-10-04 | - |
| Diagnostic assessment | 2015-10-04 | - |
| Risk assessment | 2015-10-04 | Acute non-ST segment elevation myocardial infarction (disorder) |
| Oxygen administration by mask | 2015-10-04 | - |
| Plain X-ray of chest | 2015-10-04 | - |
| Assessment of cardiac status using monitoring device | 2015-10-04 | - |
Immunizations list
| Vaccine | Date |
|---|---|
| Clostridium tetani toxoid antigen adsorbed only vaccine product | 2025-03-21 |
| Influenza virus antigen only vaccine product | 2025-03-21 |
| SARS-CoV-2 mRNA vaccine | 2021-04-02 |
Care Plan
| Immunization Recommendation | Due Date | Reason |
|---|---|---|
| Vaccine product containing only Influenza virus antigen (medicinal product) | 2025-10-01 | Annual seasonal influenza vaccination |
History of Past Illness
| Condition | Period | Status |
|---|---|---|
| Fracture of bone | 2023-09-02 – 2023-10-20 | inactive |
| Closed fracture of hip | 2023-09-02 – 2023-10-20 | inactive |
| Osteoporotic fracture | 2023-09-02 – 2023-10-20 | inactive |
| Viral sinusitis | 2020-05-22 – 2020-06-03 | inactive |
| COVID-19 | 2020-04-06 – 2020-05-01 | inactive |
| Myocardial infarction | 2015-10-04 – 2015-10-05 | inactive |
Vital Signs
| Vital Signs | 2025-03-21 | 2024-03-15 |
|---|---|---|
| Body Height | 157.6 cm | 157.6 cm |
| Pain severity - 0-10 verbal numeric rating [Score] - Reported | 2 {score} | 4 {score} |
| Body Weight | 67.5 kg | 67.5 kg |
| Body mass index (BMI) [Ratio] | 27.2 kg/m2 | 27.2 kg/m2 |
| Diastolic Blood Pressure | 79 mm[Hg] | 82 mm[Hg] |
| Systolic Blood Pressure | 114 mm[Hg] | 124 mm[Hg] |
| Heart rate | 94 /min | 65 /min |
| Respiratory rate | 15 /min | 13 /min |